ST
SNY icon

Sentinel Trust’s Sanofi SNY Stock Holding History

Sentinel Trust’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-4,878
Closed -$235K – 145
2026
Q1 		$235K Hold
4,878
– – 0.02% 128
2025
Q4 		$236K Hold
4,878
– – 0.02% 124
2025
Q3 		$230K Buy
+4,878
New +$235K 0.02% 120

Other funds holding SNY

DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
SIS
Sound Income Strategies Ft Lauderdale, Florida $2.23B AUM 11.22% 1-Year Est. Return
FBT
First Bank & Trust Brookings, South Dakota $680M AUM 25.36% 1-Year Est. Return
FB
Fulton Bank Lancaster, Pennsylvania $3.27B AUM 17.38% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
Envestnet Portfolio Solutions
Envestnet Portfolio Solutions Chicago, Illinois $20.9B AUM 19.34% 1-Year Est. Return

Sentinel Trust's SNY Position: Q2 2026 in Review

Sentinel Trust sold out of Sanofi (SNY) in Q2 2026, closing a stake of 4,878 shares — an estimated $235K sold.

Sentinel Trust first reported a position in SNY in Q3 2025 and held it in 3 quarters. The position peaked at $236K in Q4 2025. 108 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Sentinel Trust reported no remaining Sanofi position as of Q2 2026 after selling out during the quarter.
  • Sentinel Trust sold 4,878 Sanofi shares in Q2 2026, an estimated $235K.
  • Sentinel Trust first reported a position in Sanofi in Q3 2025 and held it in 3 quarters.
  • Sentinel Trust's Sanofi position peaked at $236K in Q4 2025.
  • 108 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Sentinel Trust's 13F filing for Q2 2026, filed 13 Jul 2026.